Geographic Area – Page 38

AbbVie Emerges as Leading Immunology Company in Doctor Rankings, Surpassing Pfizer and Johnson & Johnson

2 years ago talkbio0Tagged AbbVie, Drug Industry, Immunology, Johnson & Johnson, Market, Performance, Pfizer, Physicians, portfolio, product, reputation

AbbVie, Pfizer, Johnson & Johnson, doctor ranking, immunology companies, pharmaceutical industry, market performance, reputation, product portfolio.

CSL Vifor’s Corrective Marketing Initiative to Address Anti-Competitive Concerns

2 years ago talkbio0Tagged anti-competitive practices, competition, Corrective, CSHL1 gene, Drug Industry, fairness, Market, Measures, Vifor

CSL Vifor, marketing campaign, anti-competitive practices, competition law, corrective measures, pharmaceutical industry, competition watchdog, market fairness.

Sanofi Restructures US Commercial Vaccine Group Amid Cost-Saving Campaign

2 years ago talkbio0Tagged Commercial Vaccine, Cost-Savings Campaign, Effectiveness, Efficiency, Employee, Evolving, Market, Optimization, Outplacement, restructuring, sanofi, streamlined strategic sales, Structure, Vaccines

Sanofi, Restructuring, US Commercial Vaccine Group, Cost-Savings Campaign, Streamlined Strategic Sales Structure, Evolving Vaccine Market, Optimization for Efficiency and Effectiveness, Employee Support and Outplacement Assistance

Biotech Company Raises $54M to Dominate Dendritic Cell-Amplifying Vaccines Market

2 years ago talkbio0Tagged APEX1 protein, human, biotech, cornering, dendritic cell-amplifying vaccines, Immune response, Market, Regulators (device)

Biotech, $54M funding, Dendritic cell-amplifying vaccines, Market cornering, Immune response, Apex regulators

Fujifilm Diosynth Announces $1.2B Expansion in North Carolina, Aiming to Employ 1,400

2 years ago talkbio0Tagged Biopharmaceutical manufacturing, Biotechnology, CDMO facility, end-to-end cell culture, expansion, Fujifilm, Holly Springs, Investments, Japanese language, North Carolina, Occupations

Fujifilm Diosynth Biotechnologies, $1.2 billion expansion, North Carolina, Holly Springs, 1/400 jobs, Biopharmaceutical manufacturing, End-to-end cell culture CDMO facility, Japanese investment

Novartis Announces 680 Layoffs in Development Group Amid Corporate Restructuring

2 years ago talkbio0Tagged Corporate, development aspects, Drug Industry, layoffs, Novartis, restructuring, Switzerland, United States

Novartis, Layoffs, Development Group, Corporate Restructuring, 680 Jobs, Switzerland, United States, Pharmaceutical Industry

Sanofi Settles 4,000 Zantac Cancer Lawsuits, Faces Delaware Claims

2 years ago talkbio0Tagged Claims, Daubert, Delaware, Delaware Superior Court, lawsuits, sanofi, Settlement and Resettlement, Zantac

Sanofi, Zantac, Cancer Lawsuits, Settlement, Delaware Claims, 4/000 Lawsuits, Delaware Superior Court, Daubert Ruling

Experts Commend Amylyx for Withdrawing ALS Drug Relyvrio Following Trial Failure

2 years ago talkbio0Tagged Amylyx, Amyotrophic Lateral Sclerosis, Market, promise, Relyvrio, Trial failure, Withdraw (activity)

Amylyx, Relyvrio, ALS drug, Trial failure, Market withdrawal, Promise kept

Lonza Acquires Roche’s Massive Biologics Production Facility in Vacaville, California for $1.2 Billion

2 years ago talkbio0Tagged Biologics Manufacturing Site, California, Capacity, CDMOs, Contract Development, genentech, Global Biologics Market, Growth, Large-Scale Commercial Mammalian Products, Lonza, manufacturing organizations, Roche (company), utilization qualifier, Vacaville

Lonza, Roche, Genentech, Biologics Manufacturing Site, Vacaville/ California, $1.2 Billion Deal, Large-Scale Commercial Mammalian Products, Expansion Plans ($561 Million), Capacity Utilization, Contract Development and Manufacturing Organizations (CDMOs), Global Biologics Market Growth

AstraZeneca Joins Price Cap Movement for Inhalers Following Boehringer Investigation

2 years ago talkbio0Tagged AstraZeneca, Evaluation, Inhaler, Prices, SmithKline Beecham

Evaluation, Inhaler, AstraZeneca, SmithKline Beecham, Prices